TKA is one of the most frequently performed procedures in orthopedic surgery due to its proven efficacy for relieving pain and restoring mobility in patients with knee osteoarthritis. The proportion of patients that will need to undergo this procedure is expected to increase in Asian countries. Although many studies reported improvement in functional outcome after TKA, a substantial proportion of patients still described some level of dissatisfaction with the outcome of TKA. As a result, newer prosthetic designs have been developed to improve functional outcomes and to reduce the risk of complications. The ATTUNE knee system is one of those more recently designed knee systems, and its key design characteristics are modifications of two predecessor models from the same company (i.e., PFC Sigma, and Low Contact Stress [LCS] Complete Knee System). The improved anatomical design of the ATTUNE system is expected to deliver superior clinical outcomes to those expected from the PFC Sigma. Moreover, the longevity of the polyethylene is also expected to be longer in the ATTUNE prosthetic knee compared to the PFC Sigma. Studies that have compared the intermediate-term results of the ATTUNE system with other knee prosthesis systems are limited.
The ATTUNE TKA system, which represents an advancement in knee replacement technology, was expected to deliver better performance than the PFC Sigma TKA system. However and in contrast, the results of our study revealed no significant differences between the ATTUNE and PFC Sigma knee systems relative to pain, modified knee score, or performance-based measures during a minimum follow-up of 5 years. White, et al. [22] conducted a combined retrospective and prospective cohort matched-pair study that found significantly less residual pain (using yes or no questions) in the ATTUNE group than in the PFC Sigma group at the 5-year follow-up (19.5% vs. 36.3%, respectively; p = 0.02). However, when Knee Society Score (KSS) and the Western Ontario and McMaster University Osteoarthritis Index (WOMAC) were compared between the two knee systems, no significant difference between groups was observed for either measure. In addition – in those who reported residual pain, the pain symptom was only mild and occasional. Therefore, this residual pain might not be clinically important. Similar to our results, they reported no significant differences in functional outcomes, including the rate of anterior knee pain, crepitation, or modified knee score, between the two groups.
Previous studies showed that the post-TKA ROM plateaued at approximately 6 to 12 months postoperatively [23, 24]. Conversely, our study showed that the ROM continued to increase from 1-year to 5-years postoperatively in both evaluated knee systems. This may be explained by the fact that as people get older, there is a tendency for soft tissue to become more relaxed, which can lead to increased ROM [25]. Additionally, the mean ROM in the ATTUNE group was significantly higher than that of the PFC Sigma group (115.8 vs. 110 degrees, respectively; p = 0.041) at 5-years post-TKA; however, there was no significant difference between groups for TKA stability. Since ROM is multifactorial, the reason for the difference in ROM at 5 years between these two prosthetic designs is still unclear. It is possible that the ATTUNE design may provide a late improvement in ROM compared to that of the PFC Sigma. Nevertheless, the 5.8-degree gain in the ATTUNE TKA group may not be clinically important.
Although most previous studies showed no major differences between the ATTUNE and PFC Sigma systems relative to functional outcomes during a short-term follow-up [7, 26–30] (Table 4), some studies reported that the ATTUNE system had less patients who experienced crepitation and pain. Martin, et al. [29] found a lower rate of crepitation in the ATTUNE group than in the PFC Sigma group at the 2-year follow-up (0.83% vs. 9.4%, respectively). Ranawat, et al. [7] reported that ATTUNE patients had less incidence of anterior knee pain and crepitation than PFC Sigma patients; however, a longer-term follow-up study at 5-years postoperatively of the same population found no significant difference in the incidence of anterior knee pain between groups (11.7% vs. 22.1% for the ATTUNE and PFC Sigma groups, respectively; p = 0.09) [22]. The authors suggested explanation for this finding was that some patients in the earlier cohort were diseased and lost to follow-up. Thus, the 5-year study might have been underpowered to detect a difference in the occurrence of anterior knee pain. Song, et al. [30] reported that the ATTUNE group had a significantly higher knee score domain in the KSS (93.1 vs. 88.8 points for ATTUNE and PFC Sigma respectively, p < 0.001), and that ATTUNE yielded approximately 2.4 degrees more ROM than the PFC Sigma at the 2-year follow-up. This difference, however, was still within the 7.2 points of the minimal clinically important difference (MCID) of the KSS [31]. It is also important to point out that none of those previous studies evaluated functional outcome using performance-based testing like the TUG test and 2MWT. Since patient-reported outcome measure (PROM) and performance-based testing are interchangeable and equally important [32], a comprehensive evaluation of knee function should include a combination of PROM and performance-based tests to better assess functional recovery in patients after TKA.
Table 4
Literature review for previous studies that compared the outcome results between the PFC Sigma and ATTUNE knee systems
Paper
|
Year of publication
|
Type of study
|
Duration
|
Sample size
|
Outcomes
|
Findings
|
Ranawat, et al. [7]
|
2017
|
Prospective, matched-pair
|
2 years
|
200
|
KSS, anterior knee pain, crepitation, satisfaction rate
|
ATTUNE had a significantly lower incidence of anterior knee pain (12.5% vs. 25.8%, p = 0.02) and crepitation (17.7% vs. 30.9%, p = 0.02)
|
Martin, et al. [29]
|
2017
|
Retrospective
|
2 years
|
1,893
|
KSS, ROM, crepitation
|
ATTUNE had a significantly lower incidence of crepitation (0.8% vs. 9.4%, p < 0.001)
|
Song, et al. [30]
|
2018
|
Prospective
|
2 years
|
600
|
KSS, ROM, risk of patella injury
|
ATTUNE had a significantly higher knee score domain in the KSS (93.1 vs. 88.8 points, p < 0.001) and ROM (131.4 vs. 129.0 degrees, p = 0.008)
|
Chua, et al. [27]
|
2019
|
Prospective
|
2 years
|
130
|
KSS, ROM, Oxford knee score, Short Form-36, satisfaction rate
|
No significant differences in any outcome measurements
|
Molloy, et al. [28]
|
2019
|
Prospective
|
2 years
|
2,116
|
Patient-reported outcome measures, ROM, reoperative rate
|
No significant differences in any outcome measurements
|
Hauer, et al. [26]
|
2020
|
Randomized control trial
|
2 years
|
158
|
KSS, ROM, WOMAC, VAS
|
No significant differences in any outcome measurements
|
White, et al. [22]
|
2020
|
Combined prospective & retrospective, matched-pair
|
5 years
|
154
|
KSS, WOMAC, anterior knee pain, crepitation, residual pain, satisfaction rate
|
ATTUNE had a significantly lower incidence of residual pain (19.5% vs. 36.3%, p = 0.02)
|
The present study
|
|
Retrospective
|
5 year
|
113
|
Modified knee score, ROM, NRS-pain, TUG, 2MWT, anterior knee pain, crepitation, patellar clunk
|
ATTUNE had a significantly higher ROM at the 5-year postoperative follow-up (115.8 vs. 110.0 degrees, p = 0.041)
|
Abbreviations: PFC, Press Fit Condylar; KSS, Knee Society Score; ROM, range of motion; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index; VAS, visual analog scale for pain; TUG, timed up and go test; 2MWT, two-minute walk test; NRS-pain, numerical rating scale-pain
The strength of this study is that it is the first to compare the performance-based outcomes of two commonly used TKA designs at a minimum follow-up of 5 years. Our study also has some mentionable limitations. First, as with all retrospective studies, our study was subject to inherent biases in patient selection. Second, the study period was considered intermediate (range: 60 to 92 months), which may not be long enough to prove the longevity of these two prostheses. Further follow-up is needed to compare the survivorship of these two knee systems in this patient population. Third, our study used modified knee score, ROM, NRS-pain and two performance-based tests as outcome measurements. However, other knee functional scores and performance-based tests are available, and we are not able to recommend which of those metrics are best for evaluating function after TKA. The scores and tests that we used in this study may not be sensitive enough to detect statistically significant differences in knee function between the ATTUNE and PFC Sigma TKA designs. It is possible that patients with one prosthetic design could have had better postoperative function if they were asked to perform above the limits of the functional tests that were used in this study.